Drug Discovery & Screening
This session highlights high-throughput platforms utilizing specialized human cells for precise toxicity and therapeutic evaluation. Topics include target validation models, disease-in-a-dish assays, and pharmacokinetic tracking. Pharmacologists at Stem Cells 2027 will demonstrate AI-driven assay optimization. Participants will leverage human cell-based screening and accelerated pharmacological drug discovery to streamline early preclinical pipelines.